Gunjan Chandra

Dr. Gunjan Chandra

Faculty of Information Technology and Electrical Engineering, University of Oulu, Oulu, Pohjois-Pohjanmaa, Finland
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Sensors
Verified
Journal Article
Open access
PDF file
PSPekka Siirtola
Pekka Siirtola
STSatu Tamminen
Satu Tamminen
GCGunjan Chandra
Gunjan Chandra
AIAnusha Ihalapathirana
Anusha Ihalapathirana
Juha RöningJuha Röning
Juha Röning
This study aims to predict emotions using biosignals collected via wrist-worn sensor and evaluate the performance of different prediction models. Two dimensions of emotions were considered: valence and arousal. The data collected by the sensor were used in conjunction with target values obtained from questionnaires. A variety of classification and regression models were compared, including Long Short-Term Memory (LSTM) models. Additionally, the effects of different normalization methods and the impact of using different sensors were studied, and the way in which the results differed between the study subjects was analyzed. The results revealed that regression models generally performed better than classification models, with LSTM regression models achieving the best results. The normalization method called baseline reduction was found to be the most effective, and when used with an LSTM-based regression model it achieved high accuracy in detecting valence (mean square error = 0.43 and R2-score = 0.71) and arousal (mean square error = 0.59 and R2-score = 0.81). Moreover, it was found that even if all biosignals were not used in the training phase, reliable models could be obtained; in fact, for certain study subjects the best results were obtained using only a few of the sensors.

7 September 2023 in Informatics in Medicine Unlocked
Verified
Journal Article
Open access
AIAnusha Ihalapathirana
Anusha Ihalapathirana
KCKonstantina Chalkou
Konstantina Chalkou
PSPekka Siirtola
Pekka Siirtola
STSatu Tamminen
Satu Tamminen
GCGunjan Chandra
Gunjan Chandra
Juha RöningJuha Röning
Juha Röning

1 March 2025 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
GCGunjan Chandra
Gunjan Chandra
PLPiia Lavikainen
Piia Lavikainen
PSPekka Siirtola
Pekka Siirtola
STSatu Tamminen
Satu Tamminen
AIAnusha Ihalapathirana
Anusha Ihalapathirana
Juha RöningJuha Röning
Juha Röning
Purpose: This study applied machine learning (ML) and explainable artificial intelligence (XAI) to predict changes in HbA1c levels, a critical biomarker for monitoring glycemic control, within 12 months of initiating a new antidiabetic drug in patients diagnosed with type 2 diabetes. It also aimed to identify the predictors associated with these changes. Patients and Methods: Electronic health records (EHR) from 10,139 type 2 diabetes patients in North Karelia, Finland, were used to train models integrating randomized controlled trial (RCT)-derived HbA1c change values as predictors, creating offset models that integrate RCT insights with real-world data. Various ML models—including linear regression (LR), multi-layer perceptron (MLP), ridge regression (RR), random forest (RF), and XGBoost (XGB)—were evaluated using R² and RMSE metrics. Baseline models used data at or before drug initiation, while follow-up models included the first post-drug HbA1c measurement, improving performance by incorporating dynamic patient data. Model performance was also compared to expected HbA1c changes from clinical trials. Results: Results showed that ML models outperform RCT model, while LR, MLP, and RR models had comparable performance, RF and XGB models exhibited overfitting. The follow-up MLP model outperformed the baseline MLP model, with higher R² scores (0.74, 0.65) and lower RMSE values (6.94, 7.62), compared to the baseline model (R²: 0.52, 0.54; RMSE: 9.27, 9.50). Key predictors of HbA1c change included baseline and post-drug initiation HbA1c values, fasting plasma glucose, and HDL cholesterol. Conclusion: Using EHR and ML models allows for the development of more realistic and individualized predictions of HbA1c changes, accounting for more diverse patient populations and their heterogeneous nature, offering more tailored and effective treatment strategies for managing T2D. The use of XAI provided insights into the influence of specific predictors, enhancing model interpretability and clinical relevance. Future research will explore treatment selection models.

1 January 2023 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
PLPiia Lavikainen
Piia Lavikainen
GCGunjan Chandra
Gunjan Chandra
PSPekka Siirtola
Pekka Siirtola
STSatu Tamminen
Satu Tamminen
AIAnusha Ihalapathirana
Anusha Ihalapathirana
JMJanne Martikainen
Janne Martikainen
Purpose: To gain an understanding of the heterogeneous group of type 2 diabetes (T2D) patients, we aimed to identify patients with the homogenous long-term HbA1c trajectories and to predict the trajectory membership for each patient using explainable machine learning methods and different clinical-, treatment-, and socio-economic-related predictors. Patients and Methods: Electronic health records data covering primary and specialized healthcare on 9631 patients having T2D diagnosis were extracted from the North Karelia region, Finland. Six-year HbA1c trajectories were examined with growth mixture models. Linear discriminant analysis and neural networks were applied to predict the trajectory membership individually. Results: Three HbA1c trajectories were distinguished over six years: “stable, adequate” (86.5%), “improving, but inadequate” (7.3%), and “fluctuating, inadequate” (6.2%) glycemic control. Prior glucose levels, duration of T2D, use of insulin only, use of insulin together with some oral antidiabetic medications, and use of only metformin were the most important predictors for the long-term treatment balance. The prediction model had a balanced accuracy of 85% and a receiving operating characteristic area under the curve of 91%, indicating high performance. Moreover, the results based on SHAP (Shapley additive explanations) values show that it is possible to explain the outcomes of machine learning methods at the population and individual levels. Conclusion: Heterogeneity in long-term glycemic control can be predicted with confidence by utilizing information from previous HbA1c levels, fasting plasma glucose, duration of T2D, and use of antidiabetic medications. In future, the expected development of HbA1c could be predicted based on the patient’s unique risk factors offering a practical tool for clinicians to support treatment planning.

11 May 2024 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
GCGunjan Chandra
Gunjan Chandra
JWJunfeng Wang
Junfeng Wang
PSPekka Siirtola
Pekka Siirtola
JRJuha Röning
Juha Röning
Orphan diseases, exemplified by T-cell prolymphocytic leukemia, present inherent challenges due to limited data availability and complexities in effective care. This study delves into harnessing the potential of machine learning to enhance care strategies for orphan diseases, specifically focusing on allogeneic hematopoietic cell transplantation (allo-HCT) in T-cell prolymphocytic leukemia. The investigation evaluates how varying numbers of variables impact model performance, considering the rarity of the disease. Utilizing data from the Center for International Blood and Marrow Transplant Research, the study scrutinizes outcomes following allo-HCT for T-cell prolymphocytic leukemia. Diverse machine learning models were developed to forecast acute graft-versus-host disease (aGvHD) occurrence and its distinct grades post-allo-HCT. Assessment of model performance relied on balanced accuracy, F1 score, and ROC AUC metrics. The findings highlight the Linear Discriminant Analysis (LDA) classifier achieving the highest testing balanced accuracy of 0.58 in predicting aGvHD. However, challenges arose in its performance during multi-class classification tasks. While affirming the potential of machine learning in enhancing care for orphan diseases, the study underscores the impact of limited data and disease rarity on model performance.

11 December 2022 in Data
Verified
Journal Article
Open access
PDF file
GCGunjan Chandra
Gunjan Chandra
PSPekka Siirtola
Pekka Siirtola
STSatu Tamminen
Satu Tamminen
MKMikael Knip
Mikael Knip
RVRiitta Veijola
Riitta Veijola
Juha RöningJuha Röning
Juha Röning
Clinical data analysis could lead to breakthroughs. However, clinical data contain sensitive information about participants that could be utilized for unethical activities, such as blackmailing, identity theft, mass surveillance, or social engineering. Data anonymization is a standard step during data collection, before sharing, to overcome the risk of disclosure. However, conventional data anonymization techniques are not foolproof and also hinder the opportunity for personalized evaluations. Much research has been done for synthetic data generation using generative adversarial networks and many other machine learning methods; however, these methods are either not free to use or are limited in capacity. This study evaluates the performance of an emerging tool named synthpop, an R package producing synthetic data as an alternative approach for data anonymization. This paper establishes data standards derived from the original data set based on the utilities and quality of information and measures variations in the synthetic data set to evaluate the performance of the data synthesis process. The methods to assess the utility of the synthetic data set can be broadly divided into two approaches: general utility and specific utility. General utility assesses whether synthetic data have overall similarities in the statistical properties and multivariate relationships with the original data set. Simultaneously, the specific utility assesses the similarity of a fitted model’s performance on the synthetic data to its performance on the original data. The quality of information is assessed by comparing variations in entropy bits and mutual information to response variables within the original and synthetic data sets. The study reveals that synthetic data succeeded at all utility tests with a statistically non-significant difference and not only preserved the utilities but also preserved the complexity of the original data set according to the data standard established in this study. Therefore, synthpop fulfills all the necessities and unfolds a wide range of opportunities for the research community, including easy data sharing and information protection.